| __timestamp | Alnylam Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 1777824000000 |
| Thursday, January 1, 2015 | 41097000 | 1807378000000 |
| Friday, January 1, 2016 | 47159000 | 1732051000000 |
| Sunday, January 1, 2017 | 89912000 | 1770531000000 |
| Monday, January 1, 2018 | 74908000 | 2097224000000 |
| Tuesday, January 1, 2019 | 219750000 | 3291188000000 |
| Wednesday, January 1, 2020 | 492853000 | 3197812000000 |
| Friday, January 1, 2021 | 844287000 | 3569006000000 |
| Saturday, January 1, 2022 | 1037418000 | 4027478000000 |
| Sunday, January 1, 2023 | 1828292000 | 4263762000000 |
| Monday, January 1, 2024 | 2248243000 | 4263762000000 |
Cracking the code
In the competitive landscape of pharmaceuticals, revenue generation is a key indicator of a company's market strength. From 2014 to 2023, Takeda Pharmaceutical Company Limited has consistently outperformed Alnylam Pharmaceuticals, Inc. in terms of revenue. Takeda's revenue has grown steadily, reaching a peak of approximately $4.26 trillion in 2023, showcasing a robust growth trajectory. In contrast, Alnylam's revenue, while showing significant growth from $50 million in 2014 to $1.83 billion in 2023, remains a fraction of Takeda's earnings.
This stark contrast highlights Takeda's dominant market position, with revenues approximately 2,300 times greater than Alnylam's in 2023. Despite Alnylam's impressive growth rate, the gap remains substantial. This data underscores the scale and reach of Takeda in the global pharmaceutical industry, while Alnylam continues to carve out its niche with innovative therapies.
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
GSK plc or Alnylam Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Breaking Down Revenue Trends: Alnylam Pharmaceuticals, Inc. vs Viatris Inc.
Alnylam Pharmaceuticals, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. or Novavax, Inc.: Who Leads in Yearly Revenue?